Literature DB >> 25179745

Obesity and its association with generalised epilepsy, idiopathic syndrome, and family history of epilepsy.

Lady D Ladino1, Lizbeth Hernández-Ronquillo2, José F Téllez-Zenteno2.   

Abstract

Aim. Previous studies support the concept that obesity is a common comorbid condition in patients with epilepsy (PWE). In this study, we present the body mass index (BMI) and data from a survey to assess physical activity in a sample of PWE from an epilepsy clinic. Methods. Between June of 2011 and January of 2013, 100 PWE from an adult epilepsy clinic were included. We obtained BMI, waist circumference, and information regarding physical activity using a standardised questionnaire. Clinical, demographic, electrographic, and imaging parameters were collected from charts. Results. Mean age of patients was 40 ± 14 (18-77) years. The BMI distribution was as follows: 2 patients (2%) underweight, 26 (26%) normal weight, 34 (34%) overweight, 25 (25%) obese, and 13 (13%) with morbid obesity. In our study, obesity was defined as having a BMI ≥ 30. We found 38 (38%) patients in this range. There was no difference in the rate of drug-resistant epilepsy between obese and non-obese patients (55 vs. 55%; p=0.05). Leisure time habit was reported in 82% of obese patients and 79% of patients without obesity. Overall, the most frequent activity was walking (70%). Factors associated with obesity were generalised epilepsy (OR: 2.7, 1.1-6.6; p=0.012), idiopathic syndrome (OR: 2.7, 1.04-7; p=0.018), and family history of epilepsy (OR: 6.1, 1.5-24.2; p=0.002). Conclusion. Our study suggests an association between obesity, idiopathic generalised epilepsy, and family history of epilepsy. Our study shows that PWE are physically active and there is no clear relation between exercise and obesity. We could not identify any association between drug-resistant epilepsy and obesity. Absence of direct comparison with a control non-epileptic population; a cross-sectional design not allowing evaluation of a causal association among variables; and reliance on self-reported physical activity are to be considered as limitations of the present study.

Entities:  

Keywords:  body mass index; genetic syndrome; leisure activity; overweight; physical activity and waist circumference

Mesh:

Year:  2014        PMID: 25179745     DOI: 10.1684/epd.2014.0677

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  5 in total

1.  Relationship of Weight Outcomes, Co-Occurring Conditions, and Severity of Autism Spectrum Disorder in the Study to Explore Early Development.

Authors:  Susan E Levy; Jennifer A Pinto-Martin; Chyrise B Bradley; Jesse Chittams; Susan L Johnson; Juhi Pandey; Alison Pomykacz; AnnJosette Ramirez; Ann Reynolds; Eric Rubenstein; Laura A Schieve; Stuart K Shapira; Aleda Thompson; Lisa Young; Tanja V E Kral
Journal:  J Pediatr       Date:  2018-10-09       Impact factor: 4.406

2.  Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain.

Authors:  Michael S Hester; Bethany E Hosford; Victor R Santos; Shatrunjai P Singh; Isaiah J Rolle; Candi L LaSarge; John P Liska; Norberto Garcia-Cairasco; Steve C Danzer
Journal:  Exp Neurol       Date:  2016-03-17       Impact factor: 5.330

3.  High-fat diet-induced obesity exacerbates kainic acid-induced hippocampal cell death.

Authors:  Dong Ho Kang; Rok Won Heo; Chin-Ok Yi; Hwajin Kim; Chang Hwa Choi; Gu Seob Roh
Journal:  BMC Neurosci       Date:  2015-10-30       Impact factor: 3.288

4.  Neurosteroid and benzodiazepine combination therapy reduces status epilepticus and long-term effects of whole-body sarin exposure in rats.

Authors:  Lucille Lumley; Dennis Miller; William T Muse; Brenda Marrero-Rosado; Marcio de Araujo Furtado; Michael Stone; Jeffrey McGuire; Christopher Whalley
Journal:  Epilepsia Open       Date:  2019-06-18

5.  Impact of Physical Activity and Medication Adherence on the Seizure Frequency and Quality of Life of Epileptic Patients: A Population Study in West Texas.

Authors:  YoonJung Lee; Yeseul Ahn; Luca Cucullo
Journal:  Biomed Res Int       Date:  2022-01-18       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.